drugset
drugset / Trial / NCT05264922

Stromal Vascular Fraction (SVF) Cells for Non-Operative Treatment of Small Rotator Cuff Tears

NCT05264922 ↗

Phase 2 Withdrawn AdventHealth
RandomizedParallel-groupTriple-blindTreatment

Summary

The investigator's goal is to determine the effectiveness of stromal vascular fraction (SVF) cell injection to treat small rotator cuff tears without surgery.

Timeline

Start
2022-01-09
Primary completion
2022-07-22
Completion
2022-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION Cell therapy — Other
Background Fibrinogen Concentrate Human Protein / enzyme biologic — —

Indications

rotator cuff syndrome